190 related articles for article (PubMed ID: 19624248)
1. Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins.
Orienti I; Zuccari G; Carosio R; Montaldo PG
Drug Deliv; 2009 Oct; 16(7):389-98. PubMed ID: 19624248
[TBL] [Abstract][Full Text] [Related]
2. Micellar complexes of all-trans retinoic acid with polyvinylalcohol-nicotinoyl esters as new parenteral formulations in neuroblastoma.
Zuccari G; Bergamante V; Carosio R; Gotti R; Montaldo PG; Orienti I
Drug Deliv; 2009 May; 16(4):189-95. PubMed ID: 19241235
[TBL] [Abstract][Full Text] [Related]
3. Novel micelles based on amphiphilic branched PEG as carriers for fenretinide.
Orienti I; Zuccari G; Falconi M; Teti G; Illingworth NA; Veal GJ
Nanomedicine; 2012 Aug; 8(6):880-90. PubMed ID: 22094120
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic poly(vinyl alcohol) derivatives as complexing agents for fenretinide.
Orienti I; Zuccari G; Bergamante V; Mileo E; Lucarini M; Carosio R; Montaldo PG
Biomacromolecules; 2006 Nov; 7(11):3157-63. PubMed ID: 17096546
[TBL] [Abstract][Full Text] [Related]
5. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles.
Zuccari G; Carosio R; Fini A; Montaldo PG; Orienti I
J Control Release; 2005 Mar; 103(2):369-80. PubMed ID: 15763620
[TBL] [Abstract][Full Text] [Related]
6. Fenretinide-polyvinylalcohol conjugates: new systems allowing fenretinide intravenous administration.
Orienti I; Zuccari G; Bergamante V; Carosio R; Gotti R; Cilli M; Montaldo PG
Biomacromolecules; 2007 Oct; 8(10):3258-62. PubMed ID: 17883277
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration.
Carosio R; Pistoia V; Orienti I; Formelli F; Cavadini E; Mangraviti S; Montaldo PG; Ognio E; Emionite L; Zuccari G
J Pharm Pharmacol; 2012 Feb; 64(2):228-36. PubMed ID: 22221098
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled nanoparticles of dextrin substituted with hexadecanethiol.
Gonçalves C; Martins JA; Gama FM
Biomacromolecules; 2007 Feb; 8(2):392-8. PubMed ID: 17291062
[TBL] [Abstract][Full Text] [Related]
9. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
10. Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel.
Saravanakumar G; Choi KY; Yoon HY; Kim K; Park JH; Kwon IC; Park K
Int J Pharm; 2010 Jul; 394(1-2):154-61. PubMed ID: 20438818
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles.
Ledet GA; Graves RA; Glotser EY; Mandal TK; Bostanian LA
Int J Pharm; 2015 Feb; 479(2):329-37. PubMed ID: 25542987
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of oleyl alcohol anti tumor activity through complexation in polyvinylalcohol amphiphilic derivatives.
Orienti I; Zuccari G; Bergamante V; Fini A; Carosio R; Montaldo PG
Drug Deliv; 2007 Apr; 14(4):209-17. PubMed ID: 17497353
[TBL] [Abstract][Full Text] [Related]
13. Non-ionic dendritic glycerol-based amphiphiles: novel excipients for the solubilization of poorly water-soluble anticancer drug Sagopilone.
Richter A; Wiedekind A; Krause M; Kissel T; Haag R; Olbrich C
Eur J Pharm Sci; 2010 Apr; 40(1):48-55. PubMed ID: 20188825
[TBL] [Abstract][Full Text] [Related]
14. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles.
Bilensoy E; Hincal AA
Expert Opin Drug Deliv; 2009 Nov; 6(11):1161-73. PubMed ID: 19705965
[TBL] [Abstract][Full Text] [Related]
15. Non-covalent nano-adducts of co-poly(ester amide) and poly(ethylene glycol): preparation, characterization and model drug-release studies.
Legashvili I; Nepharidze N; Katsarava R; Sannigrahi B; Khan IM
J Biomater Sci Polym Ed; 2007; 18(6):673-85. PubMed ID: 17623550
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of well-defined amphiphilic block copolymers having phospholipid polymer sequences as a novel biocompatible polymer micelle reagent.
Yusa S; Fukuda K; Yamamoto T; Ishihara K; Morishima Y
Biomacromolecules; 2005; 6(2):663-70. PubMed ID: 15762627
[TBL] [Abstract][Full Text] [Related]
17. Melarsoprol-cyclodextrins inclusion complexes.
Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
[TBL] [Abstract][Full Text] [Related]
18. Surfactant solutions and porous substrates: spreading and imbibition.
Starov VM
Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
[TBL] [Abstract][Full Text] [Related]
19. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
20. Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastoma.
Corazzari M; Lovat PE; Oliverio S; Pearson AD; Piacentini M; Redfern CP
Mol Pharmacol; 2003 Dec; 64(6):1370-8. PubMed ID: 14645667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
